Comparing Rectus Sheath Catheter to Epidural Post Cystectomy
Primary Purpose
Bladder Cancer, Postoperative Pain
Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Epidural
Rectus Sheath Catheters
Sponsored by
About this trial
This is an interventional treatment trial for Bladder Cancer focused on measuring bladder cancer-cystectomy, rectus sheath catheter, epidural
Eligibility Criteria
Inclusion Criteria:
- Patients over or equal to the age of 19 years old who can understand the study protocol and are able to give consent
- Patients with an American Society of Anaesthesiology (ASA) classification 1 to 3
- Patients must have a preoperative oral 24 hour opioid consumption of less than or equal to 30mg morphine equivalents
- Patients must be able to understand and be able to use patient controlled analgesia
- Patients must be undergoing a cystectomy with an infra-umbilical midline incision
Exclusion Criteria:
- Patients with BMI greater than 40
- Patients with an allergy to local anaesthetics
- Patients who are contraindicated to having an epidural (e.g. coagulopathic, distorted anatomy, patient refusal, infection at the site of proposed insertion)
- Patients with previous spinal surgery at the proposed site of epidural
- Patients with neurodegenerative disorders or spinal cord injury
- Patients with known anatomy that would not permit placement of the rectus sheath catheters e.g. Prune Belly Syndrome
- Patients undergoing another complex abdominal procedure in addition to cystectomy and reconstruction requiring extension of the abdominal incision above the umbilicus.
Sites / Locations
- Vancouver Prostate Centre, Dept. Urologic SciencesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Rectus Sheath Catheter Group
Epidural Group
Arm Description
Patients will have rectus sheath catheters surgically inserted with infusion of 0.125% Bupivicaine at 5mls an hour.
Patients will have a standard epidural placement with infusion of 0.125% Bupivicaine at an initial rate of 5mls/hour, titrated to response
Outcomes
Primary Outcome Measures
Cumulative post-operative opioid consumption
Secondary Outcome Measures
Visual Analogue Score pain score
Patient total intraoperative Opioid requirement
Opioid requirement will be measured in morphine equivalents and reported as such on a per patient basis and measured throughout the operation.
Total patient fluid requirements throughout hospital admission
Measurement of individual patient fluid balance will be performed up to and including day 3 post-operatively.
Recorded evidence of hypotension
Hypotension for the purposes of this study is defined as a systolic blood pressure of less than 95.
Duration of post-operative ileus
Ileus will be measured by a 3 separate variables - bowel sounds, passing of flatus and opening of bowels. The post-operative day on which each of these targets is achieved for each patient will be recorded.
Time to mobilisation
Length of Hospital Stay
Patient Satisfaction with pain control
Patient satisfaction with pain control will be measured using a 9-point Likert scale on day 3 post-operatively.
Complications and side effects.
At 30 days an electronic note review will be performed to evaluate for 30 day mortality and morbidity.
Full Information
NCT ID
NCT02572804
First Posted
October 6, 2015
Last Updated
October 31, 2016
Sponsor
Vancouver Coastal Health
Collaborators
University of British Columbia, Vancouver Prostate Centre
1. Study Identification
Unique Protocol Identification Number
NCT02572804
Brief Title
Comparing Rectus Sheath Catheter to Epidural Post Cystectomy
Official Title
A Randomised Controlled Trial of Thoracic Epidural Analgesia Versus Surgically Placed Rectus Sheath Catheters for Open Radical Cystectomy: Is There a Difference in Patient Outcomes?
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Unknown status
Study Start Date
September 2015 (undefined)
Primary Completion Date
December 2016 (Anticipated)
Study Completion Date
June 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vancouver Coastal Health
Collaborators
University of British Columbia, Vancouver Prostate Centre
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a prospective randomised controlled trial that will compare the outcomes of rectus sheath catheters to epidurals in patients who have undergone a cystectomy, via a lower midline abdominal incision for bladder cancer.
Detailed Description
This study will compare the outcomes of two different pain control techniques, used as standard of care, following major abdominal surgery for bladder removal. Rectus sheath catheters are small tubes that are positioned into a specific area of the cut abdominal wall at the end of surgery; whereas an epidural is a tube that is positioned into the back. Both allow administration of local anaesthetic for pain control. The current gold standard is an epidural. This study will aim to evaluate this and show the comparative efficacy of the rectus sheath catheter, which anecdotally the investigators have found superior in practice.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bladder Cancer, Postoperative Pain
Keywords
bladder cancer-cystectomy, rectus sheath catheter, epidural
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
160 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Rectus Sheath Catheter Group
Arm Type
Active Comparator
Arm Description
Patients will have rectus sheath catheters surgically inserted with infusion of 0.125% Bupivicaine at 5mls an hour.
Arm Title
Epidural Group
Arm Type
Active Comparator
Arm Description
Patients will have a standard epidural placement with infusion of 0.125% Bupivicaine at an initial rate of 5mls/hour, titrated to response
Intervention Type
Device
Intervention Name(s)
Epidural
Intervention Description
Patients in this group will have an epidural inserted in a standard fashion, prior to the induction of anesthesia. These will be infused with 0.125% Bupivicaine at an initial rate of 5mls/hour, titrated to response. Patients will also receive a patient controlled analgesia with hydromorphone 0.2mg/ml, bolus of 200 micrograms with 6 minute lock out (variable in accordance with anesthetic preference).
Intervention Type
Device
Intervention Name(s)
Rectus Sheath Catheters
Intervention Description
Patients in this group will have surgically inserted rectus sheath catheters (bilaterally), immediately prior to closure of the anterior abdominal wall. These will be infused with 0.125% Bupivicaine at 5mls an hour at a standard rate.Patients will also receive a patient controlled analgesia with hydromorphone 0.2mg/ml, bolus of 200 micrograms with 6 minute lock out (variable in accordance with anesthetic preference).
Primary Outcome Measure Information:
Title
Cumulative post-operative opioid consumption
Time Frame
To Day 3 post-op
Secondary Outcome Measure Information:
Title
Visual Analogue Score pain score
Time Frame
within 4 hours post-operatively and on days 1, 2 and 3 post-operatively
Title
Patient total intraoperative Opioid requirement
Description
Opioid requirement will be measured in morphine equivalents and reported as such on a per patient basis and measured throughout the operation.
Time Frame
Intraoperatively
Title
Total patient fluid requirements throughout hospital admission
Description
Measurement of individual patient fluid balance will be performed up to and including day 3 post-operatively.
Time Frame
From the start of the operation to day 3 post-operatively.
Title
Recorded evidence of hypotension
Description
Hypotension for the purposes of this study is defined as a systolic blood pressure of less than 95.
Time Frame
Until Day 3 postoperatively
Title
Duration of post-operative ileus
Description
Ileus will be measured by a 3 separate variables - bowel sounds, passing of flatus and opening of bowels. The post-operative day on which each of these targets is achieved for each patient will be recorded.
Time Frame
This will be measured during the patients' inpatient hospital stay - usually up to a maximum of 10 days.
Title
Time to mobilisation
Time Frame
The day at which patient achieves mobilisation - usually at a maximum of 5 days post-operatively
Title
Length of Hospital Stay
Time Frame
The day at which patient is discharged from hospital- usually on average 10 days post-operatively
Title
Patient Satisfaction with pain control
Description
Patient satisfaction with pain control will be measured using a 9-point Likert scale on day 3 post-operatively.
Time Frame
Day 3 post operatively
Title
Complications and side effects.
Description
At 30 days an electronic note review will be performed to evaluate for 30 day mortality and morbidity.
Time Frame
30 day morbidity and mortality
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients over or equal to the age of 19 years old who can understand the study protocol and are able to give consent
Patients with an American Society of Anaesthesiology (ASA) classification 1 to 3
Patients must have a preoperative oral 24 hour opioid consumption of less than or equal to 30mg morphine equivalents
Patients must be able to understand and be able to use patient controlled analgesia
Patients must be undergoing a cystectomy with an infra-umbilical midline incision
Exclusion Criteria:
Patients with BMI greater than 40
Patients with an allergy to local anaesthetics
Patients who are contraindicated to having an epidural (e.g. coagulopathic, distorted anatomy, patient refusal, infection at the site of proposed insertion)
Patients with previous spinal surgery at the proposed site of epidural
Patients with neurodegenerative disorders or spinal cord injury
Patients with known anatomy that would not permit placement of the rectus sheath catheters e.g. Prune Belly Syndrome
Patients undergoing another complex abdominal procedure in addition to cystectomy and reconstruction requiring extension of the abdominal incision above the umbilicus.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Edmund CP Chedgy, MBBS,FRCS
Phone
+1 604-875-4111
Ext
69629
Email
echedgy@prostatecentre.com
First Name & Middle Initial & Last Name or Official Title & Degree
Geneveive Lowe, MBBS
Phone
604-875-4304
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin E Gleave, MD
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vancouver Prostate Centre, Dept. Urologic Sciences
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V6K 2H4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Edmund CP Chedgy, MBBS, FRCS
Phone
604-875-4111
Ext
69629
Email
echedgy@prostatecentre.com
First Name & Middle Initial & Last Name & Degree
Genevieve Lowe, MBBS
Phone
604-875-4304
12. IPD Sharing Statement
Citations:
PubMed Identifier
25496767
Citation
Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2015 Jun;67(6):1042-1050. doi: 10.1016/j.eururo.2014.11.043. Epub 2014 Dec 8.
Results Reference
background
PubMed Identifier
14612482
Citation
Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003 Nov 12;290(18):2455-63. doi: 10.1001/jama.290.18.2455.
Results Reference
background
PubMed Identifier
11965272
Citation
Rigg JR, Jamrozik K, Myles PS, Silbert BS, Peyton PJ, Parsons RW, Collins KS; MASTER Anaethesia Trial Study Group. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002 Apr 13;359(9314):1276-82. doi: 10.1016/S0140-6736(02)08266-1.
Results Reference
background
PubMed Identifier
10588551
Citation
Ready LB. Acute pain: lessons learned from 25,000 patients. Reg Anesth Pain Med. 1999 Nov-Dec;24(6):499-505. doi: 10.1016/s1098-7339(99)90038-x. No abstract available.
Results Reference
background
PubMed Identifier
21242424
Citation
Gustafsson UO, Hausel J, Thorell A, Ljungqvist O, Soop M, Nygren J; Enhanced Recovery After Surgery Study Group. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg. 2011 May;146(5):571-7. doi: 10.1001/archsurg.2010.309. Epub 2011 Jan 17.
Results Reference
background
PubMed Identifier
19084856
Citation
Guillotreau J, Game X, Mouzin M, Doumerc N, Mallet R, Sallusto F, Malavaud B, Rischmann P. Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery. J Urol. 2009 Feb;181(2):554-9; discussion 559. doi: 10.1016/j.juro.2008.10.011. Epub 2008 Dec 13.
Results Reference
background
PubMed Identifier
23937574
Citation
Dutton TJ, McGrath JS, Daugherty MO. Use of rectus sheath catheters for pain relief in patients undergoing major pelvic urological surgery. BJU Int. 2014 Feb;113(2):246-53. doi: 10.1111/bju.12316. Epub 2013 Aug 13.
Results Reference
background
Learn more about this trial
Comparing Rectus Sheath Catheter to Epidural Post Cystectomy
We'll reach out to this number within 24 hrs